GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK
117.4K views | +0 today
Follow
GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK
Your new post is loading...
Your new post is loading...
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

#GAFAM Réunion des actionnaires Apple: offensive à prévoir sur la santé ! #Esante #hcsmeufr #IOT #Wearable

#GAFAM Réunion des actionnaires Apple: offensive à prévoir sur la santé ! #Esante #hcsmeufr #IOT #Wearable | GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK | Scoop.it
La santé, source de nouvelles opportunités
Dans le cadre du Steve Jobs Theater, au sein du nouveau campus Apple Park à Cupertino, Tim Cook a ainsi évoqué le secteur de la santé comme un possible axe de développement, au-delà de l’offre existante (Apple Watch ou Health App). Le dirigeant reconnaît la difficulté à innover sur ce marché du fait de sa complexité, mais Cook estime toutefois que son entreprise bénéficie « d’une excellente position » pour y réussir. Il estime en effet que l’entreprise aura un réel impact dans ce domaine, car c’est son approche customer-centric qui la guidera dans le développement de ses produits, plutôt que par la capacité de ces derniers à être remboursés ou non par Medicare ou Medicaid.

Apple embarque déjà son application santé sur ses iPhone. La nouvelle mise à jour Apple iOS 11.3, qui sera disponible au printemps, permettra aux utilisateurs américains d’indexer et d’accéder à leurs données médicales via un carnet de santé numérique.

Apple n’est pas le seul acteur de la tech à s’intéresser à ce marché : Amazon, JPMorgan et Berkshire Hathaway ont lancé un consortium afin d’adresser les dépenses de santé de leurs propres employés. La maison-mère de Google, Alphabet, explore aussi le domaine, avec différentes initiatives comme les biotechs Verily ou Calico.

Par ailleurs, le patron d’Apple a indiqué être satisfait des performances de l’activité wearables (qui comprend Apple Watch, les casques Beats, ou les Airpods). Malgré des débuts contrastés, le périmètre de cette division est de taille équivalente à celui d’une entreprise du Fortune 300 (classement des entreprises aux Etats-Unis par taille de chiffre d’affaires).
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Digital Disruption in Pharma
Scoop.it!

Apple is testing whether the Apple Watch can detect heart problems

Apple is testing whether the Apple Watch can detect heart problems | GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK | Scoop.it
  • Apple is testing whether the Apple Watch can detect cardiac abnormalities.
  • The company is working on the tests with partners including Stanford and telemedicine company American Well, according to two people familiar.
  • If successful, the move could turn the watch into a 'must have' for millions of patients.
  •  

The company is partnering up with a group of clinicians at Stanford, as well as telemedicine vendor American Well, to test whether Apple Watch's heart rate sensor can detect abnormal heart rhythms in a cohort of patients, according to two people familiar.

 

Apple's Tim Cook hinted at the company's interest in heart health applications in an interview with Fortune published on Monday.

 

"We started working on the Apple Watch several years ago," he said, and one goal was "performing some measurements of your health that people were not measuring, at least continually. Like your heart. Very few people wore heart monitors. We're extremely interested in this area. And yes it is a business opportunity."

 

Cook went on to describe the medical health activity market as the "largest or second largest component" of the economy.

 

In June, CNBC reported that Apple hired Sumbul Desai, a rising star on Stanford's digital health team who was working on projects related to Apple Watch. CNBC also reported that month that Apple has been in talks with developers, hospitals and other industry groups about bringing clinical data, such as detailed lab results and allergy lists, to its devices.

 

Further Reading:


Via Pharma Guy
Pharma Guy's curator insight, September 13, 2017 7:37 AM

In May 2017, Cardiogram (cardiogr.am) and the UCSF Health eHeart Study (health-eheartstudy.org) released results showing DeepHeart, a deep neural network, can detect atrial fibrillation with 97% accuracy, using Apple Watch's heart rate sensor. DeepHeart was first trained on data from 6,158 Apple Watch owners—139 million heart rate measurements and 6,338 mobile ECGs—to identify atrial fibrillation using Apple Watch's optical heart rate sensor. DeepHeart was then tested on a separate group of 51 UCSF patients undergoing cardioversion, a heart procedure, and showed a c-statistic of 0.97 at distinguished atrial fibrillation from normal heart rhythm.

Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

Dexcom teases Apple Watch for diabetes monitoring at CES

Dexcom teases Apple Watch for diabetes monitoring at CES | GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK | Scoop.it

As digital health continues to extend into the mainstream, continuous glucose monitor (CGM) manufacturer Dexcom took advantage of the 2015 Consumer Electronics Show (CES) to unveil a simulated Apple Watch displaying live demo glucose readings from a Dexcom CGM.


As pictured on the right, the Apple Watch display is fairly similar to the current Dexcom receiver’s. It displays the current blood sugar reading, a graph of recent blood sugars, and  a trend arrow (telling the user whether their glucose trend is sharply upwards, upwards, flat, downwards, or sharply downwards). From the demo, there is no indication if the Apple Watch app will have any other features such as alarms, calibration, etc.

I believe this is the first time any diabetes device manufacturer has publicly shown any demonstration of continuous glucose data being transmitted wirelessly to a smartwatch.  The closest demonstration would be Medtronic live streaming glucose readings from their CGM to an iPhone display this past Fall.

Currently, there are no official solutions that stream glucose data to smart watches.  For the tech-savvy, a NightScout community exists that helps users “hack” their CGM’s into streaming glucose data to the cloud. In comparison, out-of-the-box synchronization to mobile devices would be a huge step for continuous glucose monitors, and the recent demos by Dexcom and Medtronic suggest that the FDA approval landscape for diabetes technology is loosening.


In a CES Digital Health session titled “Winning the War on Diabetes”, Dexcom’s Steve Pacelli (pictured second to left), Executive Vice President of Strategy and Corporate Development, announced that “[Dexcom's] 5th generation system will transfer data from the sensor to the phone.”

This would represent a significant upgrade over current G4 solutions that require a separate product (the recently approved Dexcom Share) to serve as an intermediary device between the smartphone and Dexcom receiver. Dexcom’s 5th gen release would eliminate the need for a Share-like receiver and could potentially even eliminate the receiver.

With respect to the Dexcom booth’s Apple Watch demo, it was unclear if the Apple Watch integration is coming for the Dexcom Share (and therefore current G4 systems) or for the future G5 release. However, it’s worth noting that the demo was running inside Apple’s developer kit, which means that the display was running actual software code and not just a mockup.

Furthermore, unlike Medtronic which has officially gone on record stating that Apple HealthKit integration is not part of initial plans for their upcoming smartphone systems, Dexcom’s booth prominently featured Apple Watch and Apple HealthKit in their signage.


No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Digital Disruption in Pharma
Scoop.it!

Apple Releases App to Allow Anyone with an iPhone and Apple Watch to Participate in Stanford Study of Irregular Heart Rhythms  #hcsmeufr #esante #digitalhealth

Apple Releases App to Allow Anyone with an iPhone and Apple Watch to Participate in Stanford Study of Irregular Heart Rhythms   #hcsmeufr #esante #digitalhealth | GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK | Scoop.it

Since 2009, at least 940 clinical trials using smartphones, watches or other mobile devices have been registered with ClinicalTrials.gov, a database run by the National Institutes of Health. About 290 of these were registered so far this year. Researchers are deploying the technologies to detect epileptic seizures, prevent cardiovascular disease and help U.S. combat veterans adjust to civilian life.

 

Researchers say the digital tools can make participating in medical studies more convenient for healthy volunteers and patients, helping to enroll them more quickly than in many conventional clinical trials. And built-in features such as heart-rate monitors and accelerometers can record data more accurately than study participants relying on recollection or making entries into log books, they say.

 

But researchers also see limitations, including high dropout rates by participants, as well as patient demographics that don’t always represent the broader population—partly because of the high cost of some devices. The Apple Watch costs between $249 and $399.

 

Concerns also have emerged about the privacy of participants’ health data because many of the devices and apps involve third-party vendors, said Charlene Wong, an assistant professor of pediatrics at the Duke University School of Medicine who has studied the use of technology in pediatric health care.

 

Apple will face those challenges firsthand with the study of the app’s ability to detect irregular heartbeats—a condition known as atrial fibrillation that often goes unnoticed and can lead to strokes. Anyone 22 and older with an Apple Watch will be able to participate and choose to wirelessly share their heart data with Apple and researchers at the Stanford University School of Medicine.

 

Further Reading:


Via Pharma Guy
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

Apple développerait une technique de suivi du diabète

Apple développerait une technique de suivi du diabète | GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK | Scoop.it

D'après la chaîne CNBC, le projet dont l'idée vient de Steve Jobs est mûri dans le plus grand secret. Son objectif : faciliter le suivi du diabète grâce à un outil connecté.

La technologie de pointe au service du diabète, c'est le pari qu'Apple aurait fait. D'après la chaîne américaine CNBC, le géant informatique développe depuis plusieurs années, et dans le plus grand secret, une technique destinée à faciliter le suivi du diabète via des capteurs.

Selon CNBC, le projet s'inscrit dans la lignée d'une idée qu'avait eue Steve Jobs, qui avait envisagé d'utiliser des objets - comme une montre connectée - pour mesurer différents signes physiologiques, dont la glycémie. Une telle technique permettrait aux diabétiques de s'assurer de façon continue de leur taux de glycémie et ainsi d'éviter, comme c'est actuellement le cas, de se piquer régulièrement le bout des doigts.

CNBC affirme que le projet est devenu une réalité voici plus de cinq ans - Steve Jobs étant décédé en 2011 - et qu'il est maintenant suffisamment avancé pour qu'Apple procède à des essais de faisabilité et se penche déjà sur les questions de régulation.

Le projet disposerait d'une équipe dédiée comprenant une trentaine de personne début 2016 et basée à bonne distance - plusieurs kilomètres - du siège du groupe de Cupertino (Californie).

Une telle technique, qui se baserait notamment sur des capteurs optiques et impliquerait probablement les montres "Apple Watch" lancées en 2015, placerait directement Apple sur un terrain déjà exploré depuis plusieurs années par Google puis sa maison mère, Alphabet.


No comment yet.